Patent · US Active

Kinase inhibitors and methods of use thereof

US8044083B2 · kind B2 · utility

4Cited by
51References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 2007
Grant dateOct 25, 2011
Priority date
Expiry dateAug 13, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D231/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof are useful in the treatment and prevention of various disorders mediated by kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.